Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New adjuvants on a polymethylmethacrylate base.

J Kreuter, P P Speiser

    Infection and Immunity
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    A novel adjuvant using influenza virus and methylmethacrylate polymerization enhances antibody response in animal models. This new adjuvant formulation shows superior effectiveness compared to traditional methods.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection.

    Bone marrow transplantation·2017
    Same author

    Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer.

    Journal of controlled release : official journal of the Controlled Release Society·2015
    Same author

    Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation.

    Die Pharmazie·2014
    Same author

    Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI.

    Die Pharmazie·2013
    Same author

    Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects.

    Clinical neuropathology·2009
    Same author

    Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80.

    Bulletin of experimental biology and medicine·2008

    Area of Science:

    • Immunology
    • Polymer Science

    Background:

    • Adjuvants are crucial for enhancing vaccine immunogenicity.
    • Influenza virus is a common antigen used in vaccine development.
    • Polymethylmethacrylate (PMMA) has potential as a vaccine delivery vehicle.

    Purpose of the Study:

    • To develop and evaluate a novel adjuvant system utilizing influenza virus and in-situ polymerization of methylmethacrylate.
    • To compare the immunogenicity of this new adjuvant with conventional adjuvants.

    Main Methods:

    • Influenza virus was polymerized with monomeric methylmethacrylate.
    • A comparative study involved adding influenza virus to pre-polymerized PMMA particles.
    • Antibody responses were measured in mice and guinea pigs post-vaccination.

    Related Experiment Videos

    Main Results:

    • The novel adjuvant, formed by polymerizing methylmethacrylate in the presence of influenza virus, significantly enhanced antibody response.
    • Optimal adjuvant effect was observed at 0.5% methylmethacrylate concentration.
    • This new adjuvant was more effective than adding influenza virus to pre-formed PMMA or using aluminum hydroxide.

    Conclusions:

    • In-situ polymerization of methylmethacrylate with influenza virus creates a highly effective adjuvant.
    • This novel adjuvant system offers a promising alternative to existing vaccine adjuvants.